Get the Stockscreener App
8.05
1.71%
-0.15
Lensar Inc stock is traded at $8.05, with a volume of 56,442.
It is down -1.71% in the last 24 hours and up +38.97% over the past month.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.
See More
Previous Close:
$8.20
Open:
$8.2
24h Volume:
56,442
Relative Volume:
0.55
Market Cap:
$99.02M
Revenue:
$57.70M
Net Income/Loss:
$11.98M
P/E Ratio:
-14.01
EPS:
-0.5746
Net Cash Flow:
$-12.24M
1W Performance:
+33.89%
1M Performance:
+38.97%
6M Performance:
-30.87%
1Y Performance:
-36.28%
1-Day Range:
$8.05
$8.30
1-Week Range:
$5.90
$8.74
52-Week Range:
$4.95
$12.96
Lensar Inc Stock (LNSR) Company Profile
Name
Lensar Inc
Sector
Industry
Phone
888-536-7271
Address
2800 DISCOVERY DRIVE, ORLANDO
Compare LNSR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNSR
Lensar Inc
|
8.06 | 100.74M | 57.70M | 11.98M | -12.24M | -0.5746 |
ABT
Abbott Laboratories
|
110.14 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
332.48 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
90.75 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.60 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.85 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
Lensar Inc Stock (LNSR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-01-26 | Upgrade | Lake Street | Hold → Buy |
| Mar-18-26 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-24-21 | Initiated | SVB Leerink | Outperform |
Lensar Inc Stock (LNSR) Latest News
LNSR Looks 65.7% Overvalued on GF Value™ - GuruFocus
Trading the Move, Not the Narrative: (LNSR) Edition - Stock Traders Daily
LENSAR Q2 recurring revenue hits USD 13.7M - Medical Buyer
LENSAR (NASDAQ:LNSR) Upgraded at Wall Street Zen - MarketBeat
Lensar Stock Slumps After Hours On Ending Merger Deal With Alcon Over FTC Pushback - Stocktwits
Lake Street Maintains LENSAR(LNSR.US) With Buy Rating, Maintains Target Price $13 - Moomoo
LENSAR earnings beat by $0.31, revenue topped estimates - Investing.com Canada
Q2 2026 LENSAR Inc Earnings Call Transcript - GuruFocus
Lensar Returns to Profit in Q2 on Strong Demand for ALLY Cataract System - VisionMonday.com
LENSAR Inc (LNSR) (Q2 2026) Earnings Call Highlights: Record Rev - GuruFocus
LENSAR Inc (LNSR) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability Surge - Yahoo Finance
LENSAR (LNSR) swings to profit on $39.9M H1 net income and $10M merger fee - Stock Titan
LNSR Looks 44.6% Overvalued on GF Value™ - GuruFocus
LENSAR (NASDAQ:LNSR) Posts Quarterly Earnings Results, Beats Expectations By $0.26 EPS - MarketBeat
LENSAR Q2 Earnings Call Highlights - MarketBeat
LENSAR, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
LNSR Maintained by BTIG -- Price Target Raised to $9.00 - GuruFocus
BTIG Research Forecasts Strong Price Appreciation for LENSAR (NASDAQ:LNSR) Stock - MarketBeat
Earnings call transcript: LENSAR beats on Q2 2026 profit, shares jump premarket - Investing.com Canada
LENSAR Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Lensar Q2 EPS $0.10 beats estimate; sales up 18% to $16.5M - scanx.trade
Why is LENSAR stock surging today? By Investing.com - Investing.com South Africa
Why is LENSAR stock surging today? - Investing.com India
Is LENSAR Inc (LNSR) Overvalued After Q2 Earnings? EPS: $0.13, R - GuruFocus
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Form 8K LENSAR Inc For: 13 August By Investing.com - Investing.com Nigeria
LENSAR Q2 Revenue Rises 18% as Net Income Reaches $3.5 Million - Quiver Quantitative
LENSAR Reports Q2 2026: Revenue $16.5M, Recurring Revenue $13.7M, Net Income $3.5M - TradingView
LENSAR (LNSR) swings to Q2 2026 profit as revenue and ALLY usage climb - Stock Titan
LENSAR® Reports Second Quarter 2026 Results and Provides Business Update - marketscreener.com
LENSAR Places 10 Robotic Cataract Lasers; 13 Await Installation - Stock Titan
Earnings To Watch: LENSAR Inc (LNSR) Q2 2026 -- GF Value Sees 13% Upside - Yahoo Finance
Lensar System Receives FDA Clearance - Photonics Spectra
LENSAR Shareholders Approve Directors and Executive Pay - TipRanks
LENSAR Inc (LNSR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Earnings Preview: LENSAR to Report Financial Results Pre-market on August 13 - Moomoo
LENSAR Inc (LNSR) Stock News Today - TradingKey
LENSAR® to Report Second Quarter 2026 Results on August 13th, 2026 - The Manila Times
LENSAR sets robotic cataract laser webcast for Aug. 13 - Stock Titan
LENSAR (LNSR) Dips 1.63% to $5.74: Medical Device Stock Tests Key Support ZoneEarnings Beat Stocks - dars.gov.et
LENSAR to report Q2 2026 results, host conference call - Bitget
(LNSR) Volatility Zones as Tactical Triggers - Stock Traders Daily
LENSAR Inc Annual Shareholders Meeting Transcript - GuruFocus
LNSR|LENSAR Inc|Price:5.435|Chg%:+0.425 - TradingKey
LENSAR Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
LENSAR, Inc. Revenue Breakdown – NASDAQ:LNSR - TradingView
LNSR|LENSAR Inc|Price:5.010|Chg%:-0.160 - TradingKey
LNSR Q2'26 Earnings: revenue estimate is 14.65M USD - TradingView
BlackRock, Inc. (LNSR) discloses 184,053-share beneficial stake in LENSAR - Stock Titan
LENSAR Inc (LNSR) Institutional Confidence - TradingKey
LENSAR Inc (LNSR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lensar Inc Stock (LNSR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lensar Inc Stock (LNSR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| STAAB THOMAS R II | Chief Financial Officer |
Mar 19 '26 |
Option Exercise |
2.65 |
5,500 |
14,575 |
175,959 |
2.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):